LitAlert ~~ GeneLit.com

    • Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients.
    • Kwong A, Shin VY, Ho CYS, Au CH, Slavin TP, Weitzel JN, Chan TL, Ma ESK.
    • BMC Cancer. 2020 Nov 2;20(1):1053. doi: 10.1186/s12885-020-07476-y.
    • Nipple-sparing mastectomy: A review of outcomes at a single institution.
    • Woodward S, Willis A, Lazar M, Berger AC, Tsangaris T.
    • Breast J. 2020 Nov 2. doi: 10.1111/tbj.14088. Epub ahead of print.
    • Controlled ovarian hyperstimulation for fertility preservation in women with breast cancer: Practical issues.
    • Park SY, Jeong K, Cho EH, Chung HW.
    • Clin Exp Reprod Med. 2020 Nov 2. doi: 10.5653/cerm.2020.03594. Epub ahead of print.
    • A systematic review and meta-analysis of telephone vs in-person genetic counseling in BRCA1/BRCA2 genetic testing.
    • Bracke X, Roberts J, McVeigh TP.
    • J Genet Couns. 2020 Nov 1. doi: 10.1002/jgc4.1343. Epub ahead of print.
    • PALB2 Variants: Protein Domains and Cancer Susceptibility.
    • Nepomuceno TC, Carvalho MA, Rodrigue A, Simard J, Masson JY, Monteiro ANA.
    • Trends Cancer. 2020 Oct 30:S2405-8033(20)30265-X. doi: 10.1016/j.trecan.2020.10.002. Epub ahead of print.
    • Review
    • RAD51-Mediated DNA Homologous Recombination Is Independent of PTEN Mutational Status.
    • Sinha A, Saleh A, Endersby R, Yuan SH, Chokshi CR, Brown KR, Kuzio B, Kauppinen T, Singh SK, Baker SJ, McKinnon PJ, Katyal S.
    • Cancers (Basel). 2020 Oct 29;12(11):E3178. doi: 10.3390/cancers12113178.
    • BRCA1/2 status and chemotherapy response score to tailor ovarian cancer surgery.
    • Ponzone R.
    • Crit Rev Oncol Hematol. 2020 Oct 19;157:103128. doi: 10.1016/j.critrevonc.2020.103128. Epub ahead of print.
    • Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients.
    • Grasel RS, Felicio PS, de Paula AE, Campacci N, Garcia FAO, de Andrade ES, Evangelista AF, Fernandes GC, Sabato CDS, De Marchi P, Souza CP, de Paula CAA, Torrezan GT, Galvão HCR, Carraro DM, Palmero EI.
    • Front Oncol. 2020 Oct 2;10:571330. doi: 10.3389/fonc.2020.571330.